These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12014396)

  • 1. Coumarin embryopathy: long-term follow-up of two cases.
    van Driel D; Wesseling J; de Vries TW; Sauer PJ
    Eur J Pediatr; 2002 Apr; 161(4):231-2. PubMed ID: 12014396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Warfarin fetopathy].
    Bony C; Zyka F; Tiran-Rajaofera I; Attali T; De Napoli S; Alessandri JL
    Arch Pediatr; 2002 Jul; 9(7):705-8. PubMed ID: 12162160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Embryopathy induced by oral anticoagulants].
    Jullian M; Youlton R; Rivera L
    Rev Med Chil; 1983 Oct; 111(10):1045-8. PubMed ID: 6676812
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coumarin-induced fetal abnormalities and stippled epiphyses].
    Guillot M; Toubas PL; Mselati JC; Gamarra E; Moriette G; Relier JP
    Arch Fr Pediatr; 1979 Jan; 36(1):63-6. PubMed ID: 444002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
    Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
    Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure.
    Finkelstein Y; Chitayat D; Schechter T; Keating S; Toi A; Koren G
    J Obstet Gynaecol Can; 2005 Jul; 27(7):702-6. PubMed ID: 16100627
    [No Abstract]   [Full Text] [Related]  

  • 7. Acenocoumarol and pregnancy outcome in a patient with mitral valve prosthesis: a case report.
    Stefanidis K; Papoutsis D; Daskalakis G; Loutradis D; Antsaklis A
    Fetal Diagn Ther; 2009; 25(1):115-8. PubMed ID: 19270459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth until puberty after in utero exposure to coumarins.
    Van Driel D; Wesseling J; Rosendaal FR; Odink RJ; Van der Veer E; Gerver WJ; Geven-Boere LM; Sauer PJ
    Am J Med Genet; 2000 Dec; 95(5):438-43. PubMed ID: 11146463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological outcome in school-age children after in utero exposure to coumarins.
    Wesseling J; Van Driel D; Smrkovsky M; Van der Veer E; Geven-Boere LM; Sauer PJ; Touwen BC
    Early Hum Dev; 2001 Jul; 63(2):83-95. PubMed ID: 11408097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal warfarin syndrome.
    Hou JW
    Chang Gung Med J; 2004 Sep; 27(9):691-5. PubMed ID: 15605910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorrhagic disease of the newborn infant secondary to coumarins].
    Fernández Lago C; Molero MT; Palacín A; Fidalgo I
    An Esp Pediatr; 1987 Feb; 26(2):143-4. PubMed ID: 3565956
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of anticoagulant therapy in pregnant women with artificial heart valves.
    Iturbe-Alessio I; Fonseca MC; Mutchinik O; Santos MA; Zajarías A; Salazar E
    N Engl J Med; 1986 Nov; 315(22):1390-3. PubMed ID: 3773964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring)].
    Ciorciaro C; Hartmann K; Stoller R; Kuhn M
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2109-13. PubMed ID: 8999497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of congenital warfarin syndrome due to maternal drug administration during the pregnancy.
    Dilli D; Oğuz S; Dilmen U
    Genet Couns; 2011; 22(2):221-6. PubMed ID: 21848016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulants and pregnancy. Apropos of a case of embryopathy caused by acenocoumarol].
    Lanfranchi C; Olivier C; Boudot De La Motte E; Bavoux F
    Therapie; 1982; 37(4):493-5. PubMed ID: 7135334
    [No Abstract]   [Full Text] [Related]  

  • 17. Jaundice associated with acenocoumarol exposure.
    de Bruyne EL; Jan Bac D; de Man RA; Dees A
    Neth J Med; 1998 May; 52(5):187-9. PubMed ID: 9652157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic nerve dysfunction in a child following low-dose maternal warfarin exposure.
    Khan AO
    Ophthalmic Genet; 2007 Sep; 28(3):183-4. PubMed ID: 17896319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Teratogenic effect of coumarin derivatives].
    Weenink GH; van Dijk-Wierda CA; Meyboom RH; Koppe JG; Staalman CR; Treffers PE
    Ned Tijdschr Geneeskd; 1981 May; 125(18):702-6. PubMed ID: 7231584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.